Investors may wish to note that the Chief Technology Officer of Aura Biosciences, Inc., Mark Plavsic, recently netted US$73k from selling stock, receiving an average price of US$9.85. On the bright side, that's just a small sale and only reduced their holding by 5.7%.
The Last 12 Months Of Insider Transactions At Aura Biosciences
The Independent Chairman of the Board David Johnson made the biggest insider purchase in the last 12 months. That single transaction was for US$1.4m worth of shares at a price of US$7.30 each. We do like to see buying, but this purchase was made at well below the current price of US$10.29. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.
The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.
Insider Ownership Of Aura Biosciences
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Our data indicates that Aura Biosciences insiders own about US$6.0m worth of shares (which is 1.2% of the company). Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!
So What Do The Aura Biosciences Insider Transactions Indicate?
An insider hasn't bought Aura Biosciences stock in the last three months, but there was some selling. But we take heart from prior transactions. Still, insiders don't own a great deal of the stock. So overall it's hard to argue insiders are bullish. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Case in point: We've spotted 4 warning signs for Aura Biosciences you should be aware of, and 2 of these are a bit concerning.
Of course Aura Biosciences may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
